JAK2 V617F Positive Essential Thrombocythemia Developing in a Patient with CD5⁻ Chronic Lymphocytic Leukemia.

Wei Ju,Wang Chun,Qin You-wen,Zhu Jun,Gao Yang-rong,Cai Qi,Yan Shi-ke
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2012.11.044
2012-01-01
Abstract:Coexistence of chronic lymphocytic leukemia (CLL) and essential thrombocythemia (ET) in a patient is extremely rare, with only 10 cases reported thus far in literature. This paper describes a 94-year-old male having atypical B-CLL with CD5⁻ (CD5⁻) phenotype and ET. In this patient, we performed interphase fluorescence in situ hybridization (FISH) analysis which revealed 13q14.3 deletion in 31% of B-lymphocyte nuclei and RB1 deletion in 27% of B-lymphocyte nuclei, but not in neutrophils and T-lymphocytes. Furthermore, we identified JAK2 V617F mutation in the peripheral blood nucleated cells and neutrophils, but not in the B- and T-lymphocyte populations. Therefore, it was concluded that the occurrence of CD5− B-CLL and ET in this patient was pathogenically independent.
What problem does this paper attempt to address?